An X-ray crystal structure-based understanding of the inhibition of the MDM2-p53 protein-protein interaction by isoindolinones

被引：0
|
作者：
Anil, B. [1 ]
Blackburn, E. [1 ]
Blackburn, T. [2 ]
Cully, S. [2 ]
Liu, J. [2 ]
Drummond, C. J. [2 ]
Endicott, J. A. [1 ]
Golding, B. T. [3 ]
Griffin, R. J. [2 ]
Haggerty, K. [2 ]
Lunec, J. [2 ]
Newell, D. R. [2 ]
Revill, C. H. [2 ]
Riedinger, C. [1 ]
Watson, A. F. [2 ]
Xu, Q. [2 ]
Zhao, Y. [2 ]
Hardcastle, I. R. [2 ]
Noble, M. E. M. [1 ]
机构：
[1] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England
[2] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Newcastle Univ, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70402-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
276
引用
收藏
页码：91 / 92
页数：2
相关论文
共 50 条
  • [21] Identification of a disruptor of the MDM2-p53 protein-protein interaction facilitated by high-throughput in silico docking
    Lawrence, Harshani R.
    Li, Zhenyu
    Yip, M. L. Richard
    Sung, Shen-Shu
    Lawrence, Nicholas J.
    McLaughlin, Mark L.
    McManus, Gregory J.
    Zaworotko, Michael J.
    Sebti, Said M.
    Chen, Jiandong
    Guida, Wayne C.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (14) : 3756 - 3759
  • [22] Searching for Dual Inhibitors of the MDM2-p53 and MDMX-p53 Protein-Protein Interaction by a Scaffold-Hopping Approach
    Zaytsev, Andrey
    Dodd, Barry
    Magnani, Matteo
    Ghiron, Chiara
    Golding, Bernard T.
    Griffin, Roger J.
    Liu, Junfeng
    Lu, Xiaohong
    Micco, Iolanda
    Newell, David R.
    Padova, Alessandro
    Robertson, Graeme
    Lunec, John
    Hardcastle, Ian R.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (02) : 180 - 189
  • [23] Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors
    Beck, Hilary P.
    DeGraffenreid, Michael
    Fox, Brian
    Allen, John G.
    Rew, Yosup
    Schneider, Stephen
    Saiki, Anne Y.
    Yu, Dongyin
    Oliner, Jonathan D.
    Salyers, Kevin
    Ye, Qiuping
    Olson, Steven
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (09) : 2752 - 2755
  • [24] Simulation of MDM2 N-terminal domain conformational lability in the presence of imidazoline based inhibitors of MDM2-p53 protein-protein interaction
    Gureev, Maxim
    Novikova, Daria
    Grigoreva, Tatyana
    Vorona, Svetlana
    Garabadzhiu, Alexander
    Tribulovich, Vyacheslav
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2020, 34 (01) : 55 - 70
  • [25] Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
    Zhao, Yujun
    Aguilar, Angelo
    Bernard, Denzil
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (03) : 1038 - 1052
  • [26] Transient Protein States in Designing Inhibitors of the MDM2-p53 Interaction
    Bista, Michal
    Wolf, Siglinde
    Khoury, Kareem
    Kowalska, Kaja
    Huang, Yijun
    Wrona, Ewa
    Arciniega, Marcelino
    Popowicz, Grzegorz M.
    Holak, Tad A.
    Domling, Alexander
    STRUCTURE, 2013, 21 (12) : 2143 - 2151
  • [27] Design and synthesis of non-peptidic a-helix mimics targeting for MDM2-p53 protein-protein interaction
    Zhou, Mingzhou
    Topper, Melissa E.
    Anderson, Laura
    McLaughlin, Jillian M.
    Santiago, Daniel N.
    Fronczek, Frank R.
    Guida, Wayne C.
    McLaughlin, Mark L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [28] Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity
    Brandao, Pedro
    Loureiro, Joana B.
    Carvalho, Sylvie
    Hamadou, Meriem Hadjer
    Cravo, Sara
    Moreira, Joana
    Pereira, Daniela
    Palmeira, Andreia
    Pinto, Madalena
    Saraiva, Lucilia
    Cidade, Honorina
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 156 : 711 - 721
  • [29] Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
    Shangary, Sanjeev
    Wang, Shaomeng
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2009, 49 : 223 - 241
  • [30] Flexibility is important for inhibition of the MDM2/p53 protein-protein interaction by cyclic β-hairpins
    Danelius, Emma
    Pettersson, Mariell
    Bred, Matilda
    Min, Jaeki
    Waddell, M. Brett
    Guy, R. Kiplin
    Grotli, Morten
    Erdelyi, Mate
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2016, 14 (44) : 10386 - 10393
12345